logo
  Join        Login             Stock Quote

Agilent (A) To Buy Denmark Cancer Diagnostic Co To Boost Life Science Presence

 May 17, 2012 07:15 AM
 


Agilent Technologies Inc. (NYSE:A) is acquiring Denmark-based cancer diagnostic company Dako for $2.2 billion to boost its presence in life science.

The Santa Clara, California-based provider of bio-analytical and electronic measurement services expects the deal to immediately add to its earnings on a non-GAAP basis.

Agilent said the acquisition will accelerate growth in rapidly expanding segments of diagnostic markets.

Dako, with 2010 revenue of around US$340 million, provides antibodies, reagents, scientific instruments and software. Through Dako's Reagent partnership division, Dako sells a portfolio of specific proteins and high-quality reagents for flow cytometry.

[Related -Agilent (A) Options Active As Shares Hit Highest Since '01]

The transaction is expected to be completed within the next 60 days.

Credit Suisse Securities LLC was Agilent's exclusive financial advisor in the transaction.

Agilent shares ended Wednesday's regular trading at $39.76. The stock has been trading in the 52-week range between $28.67 and $52.62.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article image7 Profitable Tech Stocks with 50-DMA turning Bullish

Lately tech has been coming out of the doldrums. That's good news for tech investors and the market as a read on...

article imageCommodity Traders Eye Strengthening Dollar

Commodity prices have been feeling the backlash of a strengthening dollar as of late, and investors it read on...

article imageThe Euro Crash?

As the US federal reserve might start soon raising interest rates and the ECB is about to being his read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.